|
PEX7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.304290E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.881500E-03 |
| Normal-vs-Stage2 |
3.813900E-02 |
| Normal-vs-Stage3 |
3.983700E-02 |
| Normal-vs-Stage4 |
1.186210E-01 |
| Stage1-vs-Stage2 |
8.626800E-01 |
| Stage1-vs-Stage3 |
7.047000E-01 |
| Stage1-vs-Stage4 |
5.356000E-01 |
| Stage2-vs-Stage3 |
7.007400E-01 |
| Stage2-vs-Stage4 |
5.731200E-01 |
| Stage3-vs-Stage4 |
7.769800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.838240E-03 |
| Normal-vs-AfricanAmerican |
4.524000E-01 |
| Normal-vs-Asian |
9.364200E-02 |
| Caucasian-vs-AfricanAmerican |
1.789580E-02 |
| Caucasian-vs-Asian |
3.123800E-01 |
| AfricanAmerican-vs-Asian |
8.360300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.537400E-03 |
| Normal-vs-Female |
3.789900E-02 |
| Male-vs-Female |
5.374400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.380200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.503900E-02 |
| Normal-vs-Age(61-80Yrs) |
9.496500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.915600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.968800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.111800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.939000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.851400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.046600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.713400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.921800E-01 |
| Classical-VS-Follicular |
8.176400E-01 |
| Classical-VS-Other |
4.471600E-01 |
| Classical-VS-Normal |
1.812240E-02 |
| Tall-VS-Follicular |
3.238800E-01 |
| Tall-VS-Other |
2.277000E-01 |
| Tall-VS-Normal |
4.485000E-01 |
| Follicular-VS-Other |
5.741600E-01 |
| Follicular-VS-Normal |
3.111600E-02 |
| Other-VS-Normal |
8.502300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.495000E-03 |
| Normal-vs-N1 |
8.378400E-03 |
| N0-vs-N1 |
6.744400E-01 |
|
|
